Geographically, North America dominated the tissue engineered - skin substitutes market driven by world class healthcare infrastructure with technological advanced practice, higher spending and presence of key industry players in the region. North America was followed by Europe and Asia-Pacific as second and third largest market for tissue engineered - skin substitutes market. Asia Pacific is projected to have the fastest growth, owing to rapidly developing medical infrastructure, increasing spending on healthcare and growing medical tourism in developing nations such as China and India in this region.
This report identifies the tissue engineered - skin substitutes market size for the years 2014-2016, and forecast of the same till the year 2022. It also highlights the market drivers, restraints, growth indicators, challenges, and other key aspects with respect to the tissue engineered - skin substitutes market.
This report segments the tissue engineered - skin substitutes market on the basis of type, application and regional market as follows:
Tissue Engineered - Skin Substitutes market research report is classified on the basis of type. Some of the major types covered in this report are as follows: Acellular, Cellular Allogeneic, Cellular Autologous, Others.
Tissue Engineered - Skin Substitutes market research report is classified on the basis of application. Some of the major applications covered in this report are as follows: Burn Injury, Diabetic/Vascular Ulcer and Others.
This report has been further segmented into major regions, which includes detailed analysis of each region such as: North America, Europe, Asia-Pacific (APAC), and Rest of the World (RoW) covering all the major country level markets in each of the region.
This report identifies all the major companies operating in the tissue engineered - skin substitutes market. Some of the major companies’ profiles in detail are as follows:
Acelity L.P., Inc.
Integra LifeSciences Corporation
Mölnlycke Health Care
Please Note: The report is to be delivered in 1-2 working days after an order is placed.
2. Executive Summary
3. Tissue Engineered - Skin Substitutes Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.3. Product Benchmarking
3.4. End User Profiling
3.5. Top 5 Financials Analysis
4. Tissue Engineered - Skin Substitutes Market– Forces
4.1.1. Rise in Geriatric Population
4.1.2. Increasing Incidence rate of Skin disorders
4.2.1. High cost
4.5. Porter’s Five Forces Analysis
4.5.1. Bargaining Power of Suppliers
4.5.2. Bargaining Power of Buyers
4.5.3. Threat of New Entrants
4.5.4. Threat of Substitutes
4.5.5. Degree of Competition
5. Tissue Engineered - Skin Substitutes Market– Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Tissue Engineered - Skin Substitutes Market, By Type
6.2. Cellular Allogeneic
6.3. Cellular Autologous
7. Tissue Engineered - Skin Substitutes Market, By Application
7.1. Burn Injury
7.2. Diabetic/Vascular Ulcer
8. Tissue Engineered - Skin Substitutes Market, By Geography
8.1.7. Rest of Europe
8.2. Asia Pacific
8.2.4. South Korea
8.2.5. Rest of Asia-Pacific
8.3. North America
8.4. Rest of the World (RoW)
8.4.2. Rest of RoW
9. Tissue Engineered - Skin Substitutes Market – Entropy
9.2. Technological Developments
9.3. Merger & Acquisitions, and Joint Ventures
9.4. Supply- Contract
10. Company Profiles (Overview, Financials, SWOT Analysis, Developments, Product Portfolio)
10.1. Acelity L.P., Inc.
10.2. BSN medical
10.3. Integra LifeSciences Corporation
10.4. Medtronic (Covidien)
10.5. Mölnlycke Health Care
10.6. Smith & Nephew plc
10.7. Organogenesis, Inc.
10.9. 3m Healthcare
10.10. Integra LifeSciences Corporation
*More than 40 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
11.3. Research Methodology
11.5. Compilation of Expert Insights